MXPA03005987A - Desproteccion enzimatica de aminas e hidroxidos. - Google Patents

Desproteccion enzimatica de aminas e hidroxidos.

Info

Publication number
MXPA03005987A
MXPA03005987A MXPA03005987A MXPA03005987A MXPA03005987A MX PA03005987 A MXPA03005987 A MX PA03005987A MX PA03005987 A MXPA03005987 A MX PA03005987A MX PA03005987 A MXPA03005987 A MX PA03005987A MX PA03005987 A MXPA03005987 A MX PA03005987A
Authority
MX
Mexico
Prior art keywords
hydroxides
amines
enzymatic deprotection
deprotection
enzymatic
Prior art date
Application number
MXPA03005987A
Other languages
English (en)
Inventor
Patel Ramesh
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of MXPA03005987A publication Critical patent/MXPA03005987A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/006Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
    • C12P41/007Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving acyl derivatives of racemic amines
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
MXPA03005987A 2001-01-04 2001-12-18 Desproteccion enzimatica de aminas e hidroxidos. MXPA03005987A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25971501P 2001-01-04 2001-01-04
PCT/US2001/049115 WO2002053724A2 (en) 2001-01-04 2001-12-18 Enzymatic deprotection of amines and hydroxides

Publications (1)

Publication Number Publication Date
MXPA03005987A true MXPA03005987A (es) 2003-09-10

Family

ID=22986070

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005987A MXPA03005987A (es) 2001-01-04 2001-12-18 Desproteccion enzimatica de aminas e hidroxidos.

Country Status (14)

Country Link
US (1) US6828119B2 (es)
EP (1) EP1348025A2 (es)
JP (1) JP4242647B2 (es)
KR (1) KR20030066799A (es)
CN (2) CN1237171C (es)
AU (1) AU2002232651B9 (es)
BR (1) BR0116486A (es)
CA (1) CA2433628A1 (es)
CZ (1) CZ20031867A3 (es)
HU (1) HUP0302539A3 (es)
IL (1) IL156356A0 (es)
MX (1) MXPA03005987A (es)
PL (1) PL364642A1 (es)
WO (1) WO2002053724A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119188B2 (en) 2001-01-04 2006-10-10 Bristol-Myers Squibb Company N-carbobenzyloxy (N-CBZ)-deprotecting enzyme and uses therefor
US7741082B2 (en) 2004-04-14 2010-06-22 Bristol-Myers Squibb Company Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
KR100887682B1 (ko) * 2007-05-29 2009-03-10 가톨릭대학교 산학협력단 한국산 미역귀 유래의 푸코이단 분해능을 보유한 신규한스핑고모나스속 균주
CN106434797A (zh) * 2016-08-25 2017-02-22 艾美科健(中国)生物医药有限公司 一种酶法合成泰拉霉素的工艺

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182654A (en) * 1974-09-18 1980-01-08 Pierce Chemical Company Production of polypeptides using polynucleotides
IL100965A (en) * 1991-02-22 1999-12-31 Univ Emory 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it
US5552397A (en) 1992-05-18 1996-09-03 E. R. Squibb & Sons, Inc. Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase
US5508272A (en) 1993-06-15 1996-04-16 Bristol-Myers Squibb Company Compounds containing a fused bicycle ring and processes therefor
AU1560095A (en) * 1994-01-06 1995-08-01 Metabolix, Inc. Methods for synthesizing oligomers containing hydroxy acid units
US5445959A (en) * 1994-07-15 1995-08-29 Eli Lilly And Company Enzyme from microbial source: phthalyl amidase
US5571796A (en) * 1995-06-06 1996-11-05 Alberta Research Council Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
US5981267A (en) * 1996-01-24 1999-11-09 The Scripps Research Institute Enantioselection of amines using homocarbonates with hydrolase
NZ336376A (en) * 1996-12-27 2000-11-24 Smithkline Beecham P Enzymatic resolution of benzodiazepine-acetic acid esters (3-oxo-2,3,4,5-1H-tetrahydro-1,4-benzodiazepine-2-acetic acid) with a lipase from Candida Antarctica
EP1156803A4 (en) 1999-02-09 2004-03-17 Bristol Myers Squibb Co FXA LACTAM INHIBITORS AND METHOD

Also Published As

Publication number Publication date
CZ20031867A3 (en) 2004-03-17
US20020123110A1 (en) 2002-09-05
WO2002053724A3 (en) 2003-01-16
JP2004520030A (ja) 2004-07-08
AU2002232651A1 (en) 2002-07-16
CN1775951A (zh) 2006-05-24
AU2002232651B2 (en) 2007-04-19
HUP0302539A2 (hu) 2003-11-28
HUP0302539A3 (en) 2010-01-28
CN1484695A (zh) 2004-03-24
CN1237171C (zh) 2006-01-18
EP1348025A2 (en) 2003-10-01
AU2002232651B9 (en) 2007-05-31
KR20030066799A (ko) 2003-08-09
WO2002053724A2 (en) 2002-07-11
JP4242647B2 (ja) 2009-03-25
US6828119B2 (en) 2004-12-07
BR0116486A (pt) 2004-08-17
PL364642A1 (en) 2004-12-13
CA2433628A1 (en) 2002-07-11
CN100359019C (zh) 2008-01-02
IL156356A0 (en) 2004-01-04

Similar Documents

Publication Publication Date Title
EP1463742A4 (en) NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
MXPA03005298A (es) Inhibidores de girasa y usos de los mismos.
EP1423120A4 (en) 2H-PHTALAZINE-1-ONES AND METHODS OF USE THEREOF
AU2002357860A8 (en) Enzymes
EP1408978A4 (en) NOVEL PHENYLAMINO-PYRIMIDINES AND THEIR USE
EP1466982A4 (en) PYROGLUTAMYL PEPTIDASE AND CORRESPONDING GENE
EG23184A (en) Targeting system and method of targeting.
MXPA03007130A (es) Conjugados de peg de hgf-nk4.
IL154553A0 (en) Urocortin-iii and uses thereof
ZA200410335B (en) Adduct of topiramate and tramadol hydrochloride and uses thereof.
AU2003235506A8 (en) Targeted enzymes and methods of making and using targeted enzymes.
AU2002303712A1 (en) Novel telomerase inhibitors and uses therefor
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
EP1408985A4 (en) NEW PYRIDOPYRIMIDONE AND ITS USES
MXPA03005987A (es) Desproteccion enzimatica de aminas e hidroxidos.
AP2003002914A0 (en) Novel expression vectors and uses thereof.
PL370031A1 (en) Novel amylases and uses thereof
GB0005326D0 (en) Enzymes and uses relating thereto
GB0109091D0 (en) Hypertension treatment and assay
GB0404489D0 (en) Ophthalmic devices and procedures
GB0121168D0 (en) Ophthalmic devices and procedures
AU2002302551A1 (en) Flavone synthase i enzymes and the use thereof
GB0109278D0 (en) Enzyme inhibitors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal